vs
Side-by-side financial comparison of EDGEWELL PERSONAL CARE Co (EPC) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
EDGEWELL PERSONAL CARE Co is the larger business by last-quarter revenue ($422.8M vs $384.8M, roughly 1.1× P3 Health Partners Inc.). EDGEWELL PERSONAL CARE Co runs the higher net margin — -15.5% vs -19.6%, a 4.1% gap on every dollar of revenue. On growth, P3 Health Partners Inc. posted the faster year-over-year revenue change (3.8% vs -11.6%). Over the past eight quarters, P3 Health Partners Inc.'s revenue compounded faster (-0.5% CAGR vs -16.0%).
The Edgewell Personal Care Company is an American multinational consumer products company headquartered in Shelton, Connecticut. It was formed in 2015 following the corporate spin-off from Energizer Holdings, Inc..
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
EPC vs PIII — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $422.8M | $384.8M |
| Net Profit | $-65.7M | $-75.5M |
| Gross Margin | 38.1% | — |
| Operating Margin | -4.5% | -40.0% |
| Net Margin | -15.5% | -19.6% |
| Revenue YoY | -11.6% | 3.8% |
| Net Profit YoY | -3028.6% | -28.8% |
| EPS (diluted) | $-1.41 | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $422.8M | $384.8M | ||
| Q3 25 | $600.5M | $345.3M | ||
| Q2 25 | $627.2M | $355.8M | ||
| Q1 25 | $580.7M | $373.2M | ||
| Q4 24 | $415.1M | $370.7M | ||
| Q3 24 | $517.6M | $362.1M | ||
| Q2 24 | $647.8M | $379.2M | ||
| Q1 24 | $599.4M | $388.5M |
| Q4 25 | $-65.7M | $-75.5M | ||
| Q3 25 | $-30.6M | $-31.6M | ||
| Q2 25 | $29.1M | $-20.4M | ||
| Q1 25 | $29.0M | $-20.5M | ||
| Q4 24 | $-2.1M | $-58.6M | ||
| Q3 24 | $8.8M | $-46.5M | ||
| Q2 24 | $49.0M | $-12.0M | ||
| Q1 24 | $36.0M | $-18.7M |
| Q4 25 | 38.1% | — | ||
| Q3 25 | 37.9% | — | ||
| Q2 25 | 42.8% | — | ||
| Q1 25 | 44.1% | — | ||
| Q4 24 | 41.6% | — | ||
| Q3 24 | 41.1% | — | ||
| Q2 24 | 44.3% | — | ||
| Q1 24 | 43.1% | — |
| Q4 25 | -4.5% | -40.0% | ||
| Q3 25 | -4.2% | -12.8% | ||
| Q2 25 | 8.6% | -9.6% | ||
| Q1 25 | 10.1% | -10.2% | ||
| Q4 24 | 2.2% | -37.4% | ||
| Q3 24 | 3.9% | -29.5% | ||
| Q2 24 | 12.8% | -8.3% | ||
| Q1 24 | 11.7% | -11.3% |
| Q4 25 | -15.5% | -19.6% | ||
| Q3 25 | -5.1% | -9.1% | ||
| Q2 25 | 4.6% | -5.7% | ||
| Q1 25 | 5.0% | -5.5% | ||
| Q4 24 | -0.5% | -15.8% | ||
| Q3 24 | 1.7% | -12.8% | ||
| Q2 24 | 7.6% | -3.2% | ||
| Q1 24 | 6.0% | -4.8% |
| Q4 25 | $-1.41 | $-23.08 | ||
| Q3 25 | $-0.65 | $-9.67 | ||
| Q2 25 | $0.62 | $-6.23 | ||
| Q1 25 | $0.60 | $-6.28 | ||
| Q4 24 | $-0.04 | $-23.13 | ||
| Q3 24 | $0.18 | $-15.70 | ||
| Q2 24 | $0.98 | $-7.37 | ||
| Q1 24 | $0.72 | $-7.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $25.0M |
| Total DebtLower is stronger | $1.5B | $228.4M |
| Stockholders' EquityBook value | $1.5B | $-155.2M |
| Total Assets | $3.8B | $656.6M |
| Debt / EquityLower = less leverage | 1.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $25.0M | ||
| Q3 25 | — | $37.7M | ||
| Q2 25 | — | $38.6M | ||
| Q1 25 | — | $40.1M | ||
| Q4 24 | — | $38.8M | ||
| Q3 24 | $209.1M | $63.0M | ||
| Q2 24 | — | $73.1M | ||
| Q1 24 | — | $27.3M |
| Q4 25 | $1.5B | $228.4M | ||
| Q3 25 | $1.4B | $252.8M | ||
| Q2 25 | $1.4B | $182.0M | ||
| Q1 25 | $1.4B | $171.1M | ||
| Q4 24 | $1.4B | $108.9M | ||
| Q3 24 | $1.3B | $133.2M | ||
| Q2 24 | $1.3B | $133.1M | ||
| Q1 24 | $1.4B | $118.1M |
| Q4 25 | $1.5B | $-155.2M | ||
| Q3 25 | $1.6B | $-18.7M | ||
| Q2 25 | $1.6B | $44.5M | ||
| Q1 25 | $1.5B | $63.3M | ||
| Q4 24 | $1.5B | $75.9M | ||
| Q3 24 | $1.6B | $120.5M | ||
| Q2 24 | $1.6B | $166.8M | ||
| Q1 24 | $1.6B | $146.6M |
| Q4 25 | $3.8B | $656.6M | ||
| Q3 25 | $3.8B | $683.6M | ||
| Q2 25 | $3.8B | $731.6M | ||
| Q1 25 | $3.8B | $783.9M | ||
| Q4 24 | $3.7B | $783.4M | ||
| Q3 24 | $3.7B | $833.3M | ||
| Q2 24 | $3.7B | $892.8M | ||
| Q1 24 | $3.8B | $855.9M |
| Q4 25 | 1.03× | — | ||
| Q3 25 | 0.89× | — | ||
| Q2 25 | 0.88× | 4.09× | ||
| Q1 25 | 0.95× | 2.71× | ||
| Q4 24 | 0.97× | 1.43× | ||
| Q3 24 | 0.81× | 1.11× | ||
| Q2 24 | 0.82× | 0.80× | ||
| Q1 24 | 0.88× | 0.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-125.9M | $-25.7M |
| Free Cash FlowOCF − Capex | $-137.5M | — |
| FCF MarginFCF / Revenue | -32.5% | — |
| Capex IntensityCapex / Revenue | 2.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $36.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-125.9M | $-25.7M | ||
| Q3 25 | $74.1M | $-15.4M | ||
| Q2 25 | $114.8M | $-16.6M | ||
| Q1 25 | $45.1M | $-33.5M | ||
| Q4 24 | $-115.6M | $-57.2M | ||
| Q3 24 | $-388.3M | $-22.6M | ||
| Q2 24 | $101.2M | $-10.2M | ||
| Q1 24 | $129.0M | $-20.0M |
| Q4 25 | $-137.5M | — | ||
| Q3 25 | $46.5M | — | ||
| Q2 25 | $99.3M | — | ||
| Q1 25 | $28.0M | — | ||
| Q4 24 | $-132.4M | — | ||
| Q3 24 | $-414.2M | — | ||
| Q2 24 | $88.6M | — | ||
| Q1 24 | $117.5M | — |
| Q4 25 | -32.5% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | -31.9% | — | ||
| Q3 24 | -80.0% | — | ||
| Q2 24 | 13.7% | — | ||
| Q1 24 | 19.6% | — |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 4.0% | 0.0% | ||
| Q3 24 | 5.0% | 0.0% | ||
| Q2 24 | 1.9% | 0.0% | ||
| Q1 24 | 1.9% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.95× | — | ||
| Q1 25 | 1.56× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -44.13× | — | ||
| Q2 24 | 2.07× | — | ||
| Q1 24 | 3.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
